Author:
Lianos Georgios D.,Mangano Alberto,Rausei Stefano,Lianou Aikaterini,Anastasiadi Zoi,Dionigi Gianlorenzo,Roukos Dimitrios H.
Publisher
Springer International Publishing
Reference91 articles.
1. Jemal A, Bray F, Center MM, Ferlay G, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.
2. Forman D, Pisani P. Gastric cancer in Japan—honing treatment, seeking causes. N Engl J Med. 2008;359(5):448–51.
3. Miao RL, Wu AW. Towards personalized perioperative treatment for advanced gastric cancer. World J Gastroenterol. 2014;20(33):11586–94
4. Kim C, Mulder K, Spratlin J. How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer. Oncologist. 2014;19:1046–55.
5. Kimura Y, Oki E, Yoshida A, et al. Significance of accurate human epidermal growth factor receptor-2 (HER2) evaluation as a new biomarker in gastric cancer. Anticancer Res. 2014;34(8):4207–12.